About Thomas Bumol, PhD
Thomas Bumol, PhD is a director at Spine BioPharma.
Thomas Bumol, PhD first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Bumol, PhD in the role, so the role may have started earlier or lasted longer.
Spine BioPharma, Inc.
Director
2022 – 2026 · New York, NY
Develops non-opioid, non-surgical treatments for people with pain-related disabilities.
Key Colleagues at Startups
The people Thomas Bumol, PhD works with at each company, as listed on that company's latest Form D.
Spine BioPharma, Inc. · Form D, Jun 5, 2026
FM
Fran Magee
Chief Technology Officer
JV
John Viscogliosi
Director
MV
Marc Viscogliosi
CEO and director
FM
Frank Cammisa, MD
Director